Biotechnology Assets Statistics
Total Valuation
BME:BST has a market cap or net worth of EUR 16.19 million. The enterprise value is 16.82 million.
| Market Cap | 16.19M |
| Enterprise Value | 16.82M |
Important Dates
The next estimated earnings date is Tuesday, April 6, 2027.
| Earnings Date | Apr 6, 2027 |
| Ex-Dividend Date | n/a |
Share Statistics
BME:BST has 74.93 million shares outstanding.
| Current Share Class | 74.93M |
| Shares Outstanding | 74.93M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 0.10% |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 5.45 |
| PB Ratio | 2.63 |
| P/TBV Ratio | 3.32 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 5.66 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.35, with a Debt / Equity ratio of 0.21.
| Current Ratio | 1.35 |
| Quick Ratio | 1.35 |
| Debt / Equity | 0.21 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -11.76 |
Financial Efficiency
Return on equity (ROE) is -35.89% and return on invested capital (ROIC) is -16.26%.
| Return on Equity (ROE) | -35.89% |
| Return on Assets (ROA) | -5.46% |
| Return on Invested Capital (ROIC) | -16.26% |
| Return on Capital Employed (ROCE) | -12.20% |
| Weighted Average Cost of Capital (WACC) | 15.09% |
| Revenue Per Employee | 114,786 |
| Profits Per Employee | -87,156 |
| Employee Count | 26 |
| Asset Turnover | 0.24 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, BME:BST has paid 370,668 in taxes.
| Income Tax | 370,668 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -29.18% in the last 52 weeks. The beta is 2.11, so BME:BST's price volatility has been higher than the market average.
| Beta (5Y) | 2.11 |
| 52-Week Price Change | -29.18% |
| 50-Day Moving Average | 0.21 |
| 200-Day Moving Average | 0.22 |
| Relative Strength Index (RSI) | 55.11 |
| Average Volume (20 Days) | 278,619 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BME:BST had revenue of EUR 2.98 million and -2.27 million in losses. Loss per share was -0.03.
| Revenue | 2.98M |
| Gross Profit | 2.78M |
| Operating Income | -1.11M |
| Pretax Income | -1.90M |
| Net Income | -2.27M |
| EBITDA | -841,333 |
| EBIT | -1.11M |
| Loss Per Share | -0.03 |
Balance Sheet
The company has 688,782 in cash and 1.32 million in debt, with a net cash position of -633,919 or -0.01 per share.
| Cash & Cash Equivalents | 688,782 |
| Total Debt | 1.32M |
| Net Cash | -633,919 |
| Net Cash Per Share | -0.01 |
| Equity (Book Value) | 6.18M |
| Book Value Per Share | 0.08 |
| Working Capital | 987,999 |
Cash Flow
In the last 12 months, operating cash flow was -657,057 and capital expenditures -981, giving a free cash flow of -658,038.
| Operating Cash Flow | -657,057 |
| Capital Expenditures | -981 |
| Depreciation & Amortization | 266,683 |
| Net Borrowing | -1.20M |
| Free Cash Flow | -658,038 |
| FCF Per Share | -0.01 |
Margins
Gross margin is 93.09%, with operating and profit margins of -37.13% and -75.93%.
| Gross Margin | 93.09% |
| Operating Margin | -37.13% |
| Pretax Margin | -63.55% |
| Profit Margin | -75.93% |
| EBITDA Margin | -28.19% |
| EBIT Margin | -37.13% |
| FCF Margin | n/a |
Dividends & Yields
BME:BST does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -14.00% |
| FCF Yield | -4.05% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
BME:BST has an Altman Z-Score of -9.57 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -9.57 |
| Piotroski F-Score | 5 |